These days, one doesn’t experience the news on these platforms before seeing the memes and reactions—the reaction and the ...

The 2026 trading year has kicked into gear, and while some stocks are already pushing higher into the green, others are ...

Humanoid robots are a dead end; the real breakthrough is a self-improving SuperNet that manufactures itself — and everything ...

The Russell 2000 index, which represents small-cap companies, outperformed the “Mag 7” stocks over the past month with 1.68% ...

AI isn’t neutral in women’s health. It involves learning from visibility gaps shaped by brand safety, search authority, and ...

AI companies such as OpenAI and Anthropic have long focused on building tools that can write code that will speed up software ...

Since the 2000s, Google Search—and later YouTube and Discover—served as the primary discovery and monetization engines for digital publishing. This relationship was symbiotic, if lopsided. Two decades ...

Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Cosmologists are increasingly entertaining a radical possibility: that the cosmos might fold back on itself so that, on the ...